“drugs” Archives

Entry Author Date Location
Chrono Therapeutics Scores $47.6M to Advance Anti-Smoking System 09/09/16 San Francisco
Organovo to Test Pre-Clinical Drugs on Bio-Printed Kidney Tissue 09/09/16 San Diego
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Rigel Touts Late-Stage Data for Platelet Drug 08/30/16 San Francisco
Synthetic Genomics Creates Host Organism Optimized for Bio Industry 08/29/16 San Diego
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Denise Pierce on Growth in Indiana’s Life Sciences Industry 08/26/16 Indiana
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
Cerulean’s Shares Routed as Cancer Drug Comes up Short Again 08/17/16 Boston
With $6M Investment, Histogen Aims to Grow Hair Business in China 08/17/16 San Diego
Roundup: FloSports, Aidant, Tech Wildcatters, Bayou Startup Showcase 08/17/16 Texas
OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again 08/16/16 Seattle
Aldeyra Surges on New Data, Another Step For Inflammation Drug 08/09/16 Boston
MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff 08/08/16 San Diego
Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer 08/05/16 Boston
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
Tobira Fails Main Goal in NASH Study, But Forges Ahead To Next Trial 07/25/16 San Francisco
After Rival Stumbles, Relypsa Gets $1.5B Buyout Bid From Galenica 07/21/16 San Francisco
Dauntless Takes Flight with New Business Model for Starting Biotechs 07/21/16 San Diego
Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics 07/20/16 San Diego
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting 07/19/16 Boston
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact 06/29/16 Boston
More Job Cuts at Infinity As AbbVie Sends Back Blood Cancer Drug 06/28/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Page 2 of 90 « previous page · next page »